Leo Laub

National Institutes of Health

Papers

1

Total Citations

21

H-Index

1

About

Leo Laub is a researcher whose work has centered on advancing virology and immunology, with a particular focus on HIV-1 neutralization assays. His major contribution lies in the development of a high-throughput HIV-1 microneutralization assay, detailed in his 2013 paper, which has garnered 21 citations. This work refined the standard approach for assessing antibodies directed against the HIV-1 Envelope glycoprotein, moving beyond traditional cell-line-based luciferase assays to enable more efficient, single-cell-level analysis of viral neutralization. By streamlining the evaluation of antibody efficacy, Laub’s method has provided a valuable tool for vaccine development and the study of immune responses. His contributions are notable for their practical impact on HIV research, offering a scalable solution that enhances throughput without sacrificing accuracy. For students and researchers in virology, Laub’s work exemplifies how methodological innovation can accelerate progress in understanding and combating complex viral pathogens, making his assay a key resource in the field.

Research Focus

Key Achievements

1
H-Index
1
Papers
21
Total Citations
21
Avg Citations/Paper
🏆 Most Cited Paper
High throughput HIV-1 microneutralization assay
21 citations · 2013
📈 Most Prolific Year: 2013 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: National Institutes of Health

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago